FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2172056540> ?p ?o ?g. }

• W2172056540 endingPage "1714" @default.
• W2172056540 startingPage "1708" @default.
• W2172056540 abstract "Acyclovir (ACV), a highly specific anti-herpetic drug, acts as a DNA chain terminator for several human herpesviruses (HHVs), including HHV-2 (HSV-2), a common human immunodeficiency virus (HIV)-1 co-pathogen. Several trials demonstrated that HSV-2 suppressive therapy using ACV or its prodrug valacyclovir (valACV) reduced plasma HIV-1 viral load (VL) in HIV-1/HSV-2 coinfected persons, and this was proposed to be due to a decrease in generalized immune activation. Recently, however, we found that ACV directly suppresses HIV-1 ex vivo in tissues free of HSV-2 but endogenously coinfected with other HHVs. Here, we asked whether valACV suppresses VL in HIV-1 infected HSV-2-seronegative persons.Eighteen HIV-1 infected HSV-2-seronegative individuals were randomly assigned in a double blind placebo-controlled, crossover trial. Eligible participants had CD4 cell counts of ≥500 cells/µL and were not taking antiretroviral therapy. Subjects in group A received 12 weeks of valACV 500 mg given twice daily by mouth followed by 2 weeks of a no treatment washout and then 12 weeks of placebo; subjects in group B received 12 weeks of placebo followed by 2 weeks of no treatment washout and then 12 weeks of valACV 500 mg twice daily.HIV-1 VL in plasma of patients treated with valACV 500 mg twice daily for 12 weeks was reduced on average by 0.37 log10 copies/mL.These data indicate that the effects of valACV on HIV-1 replication are not related to the suppression of HSV-2-mediated inflammation and are consistent with a direct effect of ACV on HIV-1 replication." @default.
• W2172056540 created "2016-06-24" @default.
• W2172056540 creator A5005987191 @default.
• W2172056540 creator A5009825760 @default.
• W2172056540 creator A5012410295 @default.
• W2172056540 creator A5018658358 @default.
• W2172056540 creator A5042388947 @default.
• W2172056540 creator A5051240459 @default.
• W2172056540 creator A5053982479 @default.
• W2172056540 creator A5067851127 @default.
• W2172056540 creator A5072899489 @default.
• W2172056540 creator A5087052821 @default.
• W2172056540 date "2015-03-03" @default.
• W2172056540 modified "2023-10-14" @default.
• W2172056540 title "Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover Trial" @default.
• W2172056540 cites W1964467627 @default.
• W2172056540 cites W1976224895 @default.
• W2172056540 cites W1981038759 @default.
• W2172056540 cites W1984755034 @default.
• W2172056540 cites W1994878012 @default.
• W2172056540 cites W2005850990 @default.
• W2172056540 cites W2010706007 @default.
• W2172056540 cites W2019492918 @default.
• W2172056540 cites W2020098597 @default.
• W2172056540 cites W2020275501 @default.
• W2172056540 cites W2026582074 @default.
• W2172056540 cites W2029124946 @default.
• W2172056540 cites W2038075095 @default.
• W2172056540 cites W2038709970 @default.
• W2172056540 cites W2046097061 @default.
• W2172056540 cites W2051321622 @default.
• W2172056540 cites W2055594999 @default.
• W2172056540 cites W2061566909 @default.
• W2172056540 cites W2079934697 @default.
• W2172056540 cites W2098256898 @default.
• W2172056540 cites W2114967009 @default.
• W2172056540 cites W2115144382 @default.
• W2172056540 cites W2119274821 @default.
• W2172056540 cites W2130073348 @default.
• W2172056540 cites W2132561169 @default.
• W2172056540 cites W2138613293 @default.
• W2172056540 cites W2146447530 @default.
• W2172056540 cites W2146973085 @default.
• W2172056540 cites W2149759731 @default.
• W2172056540 cites W2151860060 @default.
• W2172056540 cites W2156527147 @default.
• W2172056540 cites W2167876918 @default.
• W2172056540 cites W2169431633 @default.
• W2172056540 cites W2171636572 @default.
• W2172056540 cites W2177271924 @default.
• W2172056540 cites W2269974365 @default.
• W2172056540 cites W2322784837 @default.
• W2172056540 cites W2327169390 @default.
• W2172056540 cites W2950349457 @default.
• W2172056540 doi "https://doi.org/10.1093/cid/civ172" @default.
• W2172056540 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4447783" @default.
• W2172056540 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25740794" @default.
• W2172056540 hasPublicationYear "2015" @default.
• W2172056540 type Work @default.
• W2172056540 sameAs 2172056540 @default.
• W2172056540 citedByCount "10" @default.
• W2172056540 countsByYear W21720565402015 @default.
• W2172056540 countsByYear W21720565402016 @default.
• W2172056540 countsByYear W21720565402017 @default.
• W2172056540 countsByYear W21720565402018 @default.
• W2172056540 countsByYear W21720565402022 @default.
• W2172056540 crossrefType "journal-article" @default.
• W2172056540 hasAuthorship W2172056540A5005987191 @default.
• W2172056540 hasAuthorship W2172056540A5009825760 @default.
• W2172056540 hasAuthorship W2172056540A5012410295 @default.
• W2172056540 hasAuthorship W2172056540A5018658358 @default.
• W2172056540 hasAuthorship W2172056540A5042388947 @default.
• W2172056540 hasAuthorship W2172056540A5051240459 @default.
• W2172056540 hasAuthorship W2172056540A5053982479 @default.
• W2172056540 hasAuthorship W2172056540A5067851127 @default.
• W2172056540 hasAuthorship W2172056540A5072899489 @default.
• W2172056540 hasAuthorship W2172056540A5087052821 @default.
• W2172056540 hasBestOaLocation W21720565401 @default.
• W2172056540 hasConcept C126322002 @default.
• W2172056540 hasConcept C142462285 @default.
• W2172056540 hasConcept C142724271 @default.
• W2172056540 hasConcept C159047783 @default.
• W2172056540 hasConcept C168563851 @default.
• W2172056540 hasConcept C203014093 @default.
• W2172056540 hasConcept C204787440 @default.
• W2172056540 hasConcept C27081682 @default.
• W2172056540 hasConcept C3013748606 @default.
• W2172056540 hasConcept C71924100 @default.
• W2172056540 hasConcept C87813604 @default.
• W2172056540 hasConcept C90924648 @default.
• W2172056540 hasConcept C98274493 @default.
• W2172056540 hasConceptScore W2172056540C126322002 @default.
• W2172056540 hasConceptScore W2172056540C142462285 @default.
• W2172056540 hasConceptScore W2172056540C142724271 @default.
• W2172056540 hasConceptScore W2172056540C159047783 @default.
• W2172056540 hasConceptScore W2172056540C168563851 @default.
• W2172056540 hasConceptScore W2172056540C203014093 @default.
• W2172056540 hasConceptScore W2172056540C204787440 @default.

• next